Aberrations in folate metabolic pathway and altered susceptibility to autism

Psychiatric Genetics

Volumn 19, Issue 4, 2009, Pages 171-176

  Mohammad, Naushad Shaik ^a   Jain, Jamal Md Nurul ^a   Chintakindi, Krishna Prasad ^a   Singh, Ram Prakash ^a   Naik, Usha ^b   Akella, Radha Rama Devi ^a  

^a Center for DNA Fingerprinting and Diagnostics (CDFD)   (India)

^b Niloufer Hospital India   (India)

Author keywords

Autism; Methionine synthase reductase; Methylene tetrahydrofolate reductase; Serine hydroxymethyl transferase; Single nucleotide polymorphisms; Susceptibility

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE;

ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; FOLATE METABOLISM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 68949191031     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32832cebd2     Document Type: Article

References (33)

1. Bailey A, LeCouteur A, Gottesman I, Bolton P, Simonoff E, Yuzsa E, Rutter M (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25:63-77.
2. Boris M, Goldblatt A, Galanko J, Jill James S (2004). Association of MTHFR gene variants with autism. J Am Phys Surg 9:106-108.
3. Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, et al. (2003). Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet 11:671-678.
4. Chiang PK (1998). Biological effects of inhibitors of S-adenosyl homocysteine hydrolase. Pharmacol Ther 77:115-134.
5. Folstein SE, Piven J (1991). Etiology of autism: genetic influences. Pediatrics 87:767-773.
6. Frost P, Bloom HJ, Miles R, Gazette P, Sheppard CA, Matthews RG, et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylene tetrahydrofolate reductase. Nat Genet 10:111-113.
7. Gaughan DJ, Kluijtmans LAJ, Barbaux S, McMaster D, Young IS, Yarnell JWG, et al. (2001). The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157:451-456.
8. Geier DA, Geier MR (2004). A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit 10:PI33-PI39.
9. Girgis S, Suh JR, Jolivet J, Stover PJ (1997). 5-formyltetrahydrofolate regulates homocysteine remethylation in human neuroblastoma. J Biol Chem 272:4729-4734.
10. Heil SG,van der Put NMJ, Waas ET, den Heijer M,Trijbels FJM, Blom HJ (2001). Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 73:164-172.
11. Herbig K, Chiang EP, Lee LR, Hills J, Shane B, Stover PJ (2002). Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J Biol Chem 277:38381-38389.
12. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004). Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611-1617.
13. James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, et al. (2006). Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet141:947-956.
14. Jiang YH, Sahoo T, Michaelis RC, Bercovich D, Bressler J, Kashork CD, et al. (2004). A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A 131:1-10.
15. Kidd PM (2002). Autism, an extreme challenge integrative medicine. Part 1. The knowledge base. Altern Med Rev 7:292-316.
16. Lelord G, Callaway E, Muh JP (1982). Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children. Acta Vitaminol Enzymol 4:27-44.
17. Moretti P, Sahoo T, Hyland K, Bottiglieri T, Peters S, del Gaudio D, et al. (2005). Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology 64:1088-1090.
18. Naushad SM, Jain Jamal MN, Prasad CK, Rama Devi AR (2008). Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians. Clin Chem Lab Med 46:4673-4679.
19. Nye C, Brice A (2005). Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev 19:CD003497. Review.
20. Radha Rama Devi A, Govindaiah V, Ramakrishna G, Naushad SM (2004). Prevalence of methylene tetrahydrofolate reductase (MTHFR) gene polymorphism in South India. Curr Sci 86:440-444.
21. Rimland B (1988). Controversies in the treatment of autistic children: vitamin and drug therapy. J Child Neurol 3:S68-S72.
22. Schatz RA, Wilens TE, Sellinger OZ (1981). Decreased transmethylation of iogenic amines after in vivo elevation of brain S-adenosyl-L-homocysteine. J Neurochem 36:1739-1 748.
23. Schneider JA, Rees DC, Liu YT, Clegg JB (1998). Worldwide distribution of a common methylene tetrahydrofolate reductase mutation. Am J Hum Genet 62:1258-1260.
24. Silaste ML, Rantala M, Sämpi M, Alfthan G, Aro A, Kesäniemi YA (2001). Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr 131:2643-2647.
25. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR, et al. (2002). Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99:3786-3791.
26. Van der Put NMJ, Gabreëls F, Stevens EMB, Smeitink JAM, Trijbels FJM, Eskes TKAB, et al. (1998). A second common mutation in the methylene tetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051. (Pubitemid 28199004)
27. Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, et al. (2004). Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry 9:358-370.
28. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. (1999). A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67:317-323.
29. Xu X, Gammon MD, Zhang H, Wetmur JG, Rao M, Teitelbaum SL, et al. (2007). Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 28:1504-1509.
30. Yamada K, Chen Z, Rozen R, Matthews RG (2001). Effects of common polymorphisms on the properties of recombinant human methylene tetrahydrofolate reductase. Proc Natl Acad Sci USA 98:14853-14858.
31. Yamada K, Gravel R A, Toraya T, Matthews RG (2006). Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proc Natl Acad Sci 103:9476-9481.
32. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hines RJ, James SJ (2000). Increase in plasma homocysteine associated with parallel increases in plasma S-adenosyl homocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275:29318-29323.
33. Zhu H, Wicker NJ, Shaw GM, Lammer EJ, Hendricks K, Suarez L, et al. (2003). Homocysteine remethylation enzyme polymorphisms and increased risk for neural tube defects. Mol Genet Metab 78:216-221. (Pubitemid 36332023)